Cited by 218Parkinson's Disease Mechanisms and TreatmentsAutophagy in Disease and TherapyUbiquitin and proteasome pathways

Phosphatase and Tensin Homolog (PTEN)-induced Putative Kinase 1 (PINK1)-dependent Ubiquitination of Endogenous Parkin Attenuates Mitophagy

Open access
Rakovic, Aleksandar, Shurkewitsch, Katharina, Seibler, Philip, Grünewald, Anne, Zanon, Alessandra, Hagenah, Johann, Krainc, Dimitri, Klein, Christine·2013·Journal of Biological Chemistry

Abstract

Mutations in the E3 ubiquitin ligase Parkin and the mitochondrial PTEN-induced putative kinase 1 (PINK1) have been identified to cause autosomal recessive forms of familial Parkinson disease, with PINK1 functioning upstream of Parkin in a pathway important for the maintenance of mitochondrial function and morphology. Upon the loss of the mitochondrial membrane potential, Parkin translocates to mitochondria in a PINK1-dependent manner to ubiquitinate mitochondrial proteins. Parkin-mediated polyubiquitination of outer mitochondrial membrane (OMM) proteins recruits the ubiquitin- and LC3-binding adaptor protein p62 to mitochondria and induces mitophagy. Although previous studies examined mitophagy in established cell lines through overexpression approaches, there is an imperative to study the role of endogenous Parkin and PINK1 in human-derived and biologically relevant cell models. Here, we demonstrate in human primary fibroblasts and induced pluripotent stem-derived neurons from controls and PINK1 mutation carriers that endogenous levels of Parkin are not sufficient to initiate mitophagy upon loss of the mitochondrial membrane potential, caused by its (self-)ubiquitination, followed by degradation via the ubiquitin proteasome system. Next, we showed differential PINK1-dependent, Parkin-mediated ubiquitination of OMM proteins, which is Parkin dose-dependent and affects primarily OMM proteins of higher molecular mass. In contrast to the situation fibroblasts, we did not detect mitophagy in induced pluripotent stem-derived neurons even upon overexpression of Parkin. Taken together, our data demonstrate that mitophagy differs between human non-neuronal and neuronal cells and between "endogenous" and "Parkin-overexpressing" cellular models. Background: The Parkinson disease-related proteins PINK1 and Parkin initiate mitophagy of damaged mitochondria. Results: Endogenous Parkin is not sufficient to induce mitophagy due to PINK1-dependent ubiquitination of Parkin. Conclusion: Mitophagy is detectable only with supraphysiological levels of Parkin and differs between fibroblasts and iPS-derived neurons. Significance: Stresses the importance of future studies in Parkinson disease-relevant tissue, i.e. , dopaminergic neurons.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1074/jbc.m112.391680

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Proteasomal degradation of parkin occurs during mitophagy due to autoubiquitination, halting its activity.

    “Proteasomal degradation of parkin was demonstrated during mitophagy due to autoubiquitination, halting its activity28,29,33,34.”

    From Altered mitochondrial dynamics and function in APOE4-expressing astrocytes (2020) · cites this paper as [29]

    The Discussion (page not provided) says endogenous Parkin becomes self-ubiquitinated during mitochondrial depolarization and is likely degraded through the ubiquitin–proteasome system. It proposes that this reduces the Parkin available to translocate to mitochondria, attenuating further mitophagy; it does not demonstrate that Parkin’s activity halts. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Parkin labels mitochondria for mitophagy by ubiquitinating specific mitochondrial proteins; parkin is then degraded by the proteasome/lysosome due to autoubiquitination.

    “Parkin labels mitochondria for mitophagy by ubiquitinating specific mitochondrial proteins; parkin is then degraded by the proteasome/lysosome due to autoubiquitination26–29.”

    From Altered mitochondrial dynamics and function in APOE4-expressing astrocytes (2020) · cites this paper as [29]

    The Discussion reports Parkin-mediated ubiquitination of multiple outer mitochondrial membrane proteins and says endogenous Parkin is self-ubiquitinated and likely degraded through the ubiquitin–proteasome system. It does not support lysosomal degradation of Parkin, and describes proteasomal degradation as likely rather than established. Page numbers are not available in our copy. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • APOE4 astrocytes exhibit increased parkin levels.

    “increased parkin levels (targets mitochondria for mitophagy, followed by proteasomal/lysosomal degradation26–29)”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Vives-Bauza, C., Zhou, C., Huang, Y., Cui, M., de Vries, R. L., Kim, J., May, J., Tocilescu, M. A., Liu, W., Ko, H. S., Magrané, J., Moore, D. J., Dawson, V. L., Grailhe, R., Dawson, T. M., Li, C., Tieu, K., and Przedborski, S. (2010) PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc. Natl. Acad. Sci. U.S.A. 107, 378 -383
  2. Kim, K. Y., Stevens, M. V., Akter, M. H., Rusk, S. E., Huang, R. J., Cohen, A., Noguchi, A., Springer, D., Bocharov, A. V., Eggerman, T. L., Suen, D. F., Youle, R. J., Amar, M., Remaley, A. T., and Sack, M. N. (2011) Parkin is a lipid-responsive regulator of fat uptake in mice and mutant human cells. J. Clin. Invest. 121, 3701-3712
  3. Ziviani, E., Tao, R. N., and Whitworth, A. J. (2010) Drosophila Parkin requires PINK1 for mitochondrial translocation and ubiquitinates mito- fusin. Proc. Natl. Acad. Sci. U.S.A. 107, 5018 -5023
  4. Sterky, F. H., Lee, S., Wibom, R., Olson, L., and Larsson, N. G. (2011) Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc. Natl. Acad. Sci. U.S.A. 108, 12937-12942

Cited by

Sorted by citations

Authors
Rakovic, A., Shurkewitsch, K., Seibler, P., Grünewald, A., Zanon, A., Hagenah, J., Krainc, D., & Klein, C.
Affiliations
  • University of Lübeck (DE)
  • Eurac Research (IT)
  • Harvard University (US)
Corresponding author
Klein, Christine
Venue
Journal of Biological Chemistry
Publisher
Elsevier BV
Published
2013-01
Volume
288
Issue
4
Pages
2223-2237
ISSN
0021-9258 (ISSN-L)
OpenAlex
W2053071811
Cited by
218
References
6
Citations by year
2026: 7 · 2025: 7 · 2024: 10 · 2023: 4 · 2022: 13 · 2021: 12 · 2020: 23 · 2019: 11 · 2018: 23 · 2017: 25 · 2016: 18 · 2015: 25 · 2014: 22 · 2013: 17
FWCI
12.60
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-sa)
Funders
  • Hermann und Lilly Schilling-Stiftung für Medizinische Forschung
  • Fritz Thyssen Stiftung
Topics
  • Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
  • Health Sciences › Medicine › Epidemiology › Autophagy in Disease and Therapy
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
Keywords
Parkin, PINK1, mitophagy, ubiquitination, Parkinson's disease, mitochondrial membrane potential, mitochondrial outer membrane proteins, p62, ubiquitin-proteasome system, human fibroblasts, familial Parkinson's disease, E3 ubiquitin ligase
MeSH terms
PTEN-Induced Putative Kinase, Cell Line, Dose-Response Relationship, Drug, Fibroblasts, Homozygote, Humans, Lung, Microscopy, Fluorescence, Mitochondria, Models, Biological, Mutation, Neurons, Parkinson Disease, Protein Kinases, Stem Cells, Mutation, Missense, Ubiquitin, Ubiquitin-Protein Ligases, Induced Pluripotent Stem Cells, Mitophagy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review